Holen Sie sich die Stockscreener-App
0.4425
0.68%
0.003
Finanzdaten der Humacyte Inc-Aktie (HUMA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
17.98%
0.406
|
0.495 | 0.467 | 0.753 | 0.301 |
| Cost Of Revenue |
39.60%
1.231
|
2.038 | 9.082 | 0.26 | 0.213 |
| Research and Development |
6.77%
18.14
|
19.46 | 14.61 | - | - |
| Costs And Expenses |
6.89%
27.40
|
29.43 | 31.30 | 25.14 | 30.03 |
| Operating Income/Loss |
6.70%
-27.00
|
-28.93 | -30.84 | -24.39 | -29.73 |
| Nonoperating Income/Loss |
186.66%
-9.806
|
11.32 | 6.032 | 6.88 | -7.931 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
Net Income/Loss
|
108.88%
-36.80
|
-17.62 | -24.80 | -17.51 | -37.66 |
| Basic Average Shares |
18.37%
234.18
|
197.85 | - | 158.31 | 155.44 |
| Diluted Average Shares |
18.37%
234.18
|
197.85 | - | 158.31 | 155.44 |
| Basic Earnings Per Share |
77.78%
-0.16
|
-0.09 | - | -0.11 | -0.24 |
| Diluted Earnings Per Share |
77.78%
-0.16
|
-0.09 | - | -0.11 | -0.24 |
| Undistributed Earnings/Loss Allocated To Participating Securities, Basic |
-
|
- | - | - | - |
2.40%
0.96%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):